Drug details

Erelzi (etanercept-szzs injection)

type of DMARDs, TNF Inhibitors, Antipsoriatics, Systemic

Erelzi (etanercept-szzs) injection, for subcutaneous use is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis (RA), polyarticular juvenile idiopathic arthritis (JIA) in patients aged 2 years or older, psoriatic arthritis (PsA), ankylosing spondylitis (AS), and plaque psoriasis (PsO).

The drug is often used to treat Ankylosing spondylitis , Arthritis , Psoriatic arthritis .

This drug may have the following side effects:

• rash,
• diarrhea,
• hives, and
• fever.
• infections,
• injection site reactions (redness, itching, pain, swelling, bleeding, bruising),

The following drugs are related to Erelzi, either as a replacement or used together:

• Cibinqo (abrocitinib tablets)
• Kimyrsa (oritavancin for injeciton)
• Vtama (tapinarof cream)